A Simple Chinese Risk Score Model for Screening Cardiovascular Autonomic Neuropathy-Reference-Cited by-全球学者库

A Simple Chinese Risk Score Model for Screening Cardiovascular Autonomic Neuropathy

Published:2014-03-12 Issue:3 Volume:9 Page:e89623
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ge Xiaoli,Pan Shu-Ming,Zeng Fangfang,Tang Zi-Hui,Wang Ying-Wei

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference25 articles.

1. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management;V Spallone;Diabetes Metab Res Rev,2011

2. Links between metabolic syndrome and cardiovascular autonomic dysfunction;G Garruti;Exp Diabetes Res,2012

3. Cardiovascular autonomic dysfunction in type 2 diabetes mellitus and essential hypertension in a South Indian population;MA Hazari;Neurosciences (Riyadh),2012

4. Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance;T Laitinen;Diabet Med,2011

5. Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences;V Iodice;J Neurol Sci,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of risk prediction model for diabetic neuropathy among diabetes mellitus patients at selected referral hospitals, in Amhara regional state Northwest Ethiopia, 2005–2021;PLOS ONE;2023-08-29

2. Cardiovascular autonomic neuropathy is associated with increased glycemic variability driven by hyperglycemia rather than hypoglycemia in patients with diabetes;Diabetes Research and Clinical Practice;2023-06

3. Autonomic neuropathic symptoms in patients with diabetes: practical tools for screening in daily routine;Diabetology & Metabolic Syndrome;2023-04-26

4. Prediction of the risk for diabetic neuropathy among diabetes mellitus patients at selected referral hospitals, in Amhara regional state Northwest Ethiopia, January, 2005- December 2021; Development and validation of risk prediction model;2022-10-11

5. Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management;Clinical Therapeutics;2022-10